These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 16029022

  • 1. A peptide carrier with a built-in vaccine adjuvant: construction of immunogenic conjugates.
    Krikorian D, Panou-Pomonis E, Voitharou C, Sakarellos C, Sakarellos-Daitsiotis M.
    Bioconjug Chem; 2005; 16(4):812-9. PubMed ID: 16029022
    [Abstract] [Full Text] [Related]

  • 2. A palmitoyl-tailed sequential oligopeptide carrier for engineering immunogenic conjugates.
    Kargakis M, Zevgiti S, Krikorian D, Sakarellos-Daitsiotis M, Sakarellos C, Panou-Pomonis E.
    Vaccine; 2007 Sep 17; 25(37-38):6708-12. PubMed ID: 17692437
    [Abstract] [Full Text] [Related]

  • 3. A complementary La/SSB epitope anchored to Sequential Oligopeptide Carrier regulates the anti-La/SSB response in immunized animals.
    Voitharou C, Krikorian D, Sakarellos C, Sakarellos-Daitsiotis M, Panou-Pomonis E.
    J Pept Sci; 2008 Sep 17; 14(9):1069-76. PubMed ID: 18618423
    [Abstract] [Full Text] [Related]

  • 4. No evidence of epitope spreading after immunization with the major Sm epitope P-P-G-M-R-P-P anchored to sequential oligopeptide carriers (SOCs).
    Vlachoyiannopoulos PG, Petrovas C, Tzioufas AG, Alexopoulos C, Tsikaris V, Guialis A, Nakopoulou L, Sakarellos-Daitsiotis M, Sakarellos C, Davaris P, Moutsopoulos HM.
    J Autoimmun; 2000 Feb 17; 14(1):53-61. PubMed ID: 10648116
    [Abstract] [Full Text] [Related]

  • 5. The position of the LysN epsilon H2-grafted antigens along the sequential oligopeptide carrier, Ac-(Aib-Lys-Aib-Gly)n (SOCn-II), influences the antibody recognition: application to the Sm main autoimmune epitope.
    Alexopoulos C, Tsikaris V, Rizou C, Sakarellos-Daitsiotis M, Sakarellos C, Cung MT, Marraud M, Vlachoyiannopoulos PG, Moutsopoulos HM.
    Biopolymers; 2000 Jul 17; 54(1):1-10. PubMed ID: 10799976
    [Abstract] [Full Text] [Related]

  • 6. Influenza virus H5N1 hemagglutinin (HA) T-cell epitope conjugates: design, synthesis and immunogenicity.
    Skarlas T, Zevgiti S, Droebner K, Panou-Pomonis E, Planz O, Sakarellos-Daitsiotis M.
    J Pept Sci; 2011 Mar 17; 17(3):226-32. PubMed ID: 21308879
    [Abstract] [Full Text] [Related]

  • 7. Aldehyde modification of peptide immunogen enhances protein-reactive antibody response to toxic shock syndrome toxin-1.
    Bavoso A, Ostuni A, De Vendel J, Pollaro F, Armentano F, Knight T, Makker S, Tramontano A.
    J Pept Sci; 2006 Dec 17; 12(12):843-9. PubMed ID: 17131300
    [Abstract] [Full Text] [Related]

  • 8. A new intranasal influenza vaccine based on a novel polycationic lipid--ceramide carbamoyl-spermine (CCS) I. Immunogenicity and efficacy studies in mice.
    Joseph A, Itskovitz-Cooper N, Samira S, Flasterstein O, Eliyahu H, Simberg D, Goldwaser I, Barenholz Y, Kedar E.
    Vaccine; 2006 May 01; 24(18):3990-4006. PubMed ID: 16516356
    [Abstract] [Full Text] [Related]

  • 9. Molecular adjuvant effects of a conformationally biased agonist of human C5a anaphylatoxin.
    Tempero RM, Hollingsworth MA, Burdick MD, Finch AM, Taylor SM, Vogen SM, Morgan EL, Sanderson SD.
    J Immunol; 1997 Feb 01; 158(3):1377-82. PubMed ID: 9013982
    [Abstract] [Full Text] [Related]

  • 10. Identifying B and T cell epitopes and studying humoral, mucosal and cellular immune responses of peptides derived from V antigen of Yersinia pestis.
    Khan AA, Babu JP, Gupta G, Rao DN.
    Vaccine; 2008 Jan 17; 26(3):316-32. PubMed ID: 18096277
    [Abstract] [Full Text] [Related]

  • 11. A comparative study of different presentation strategies for an HIV peptide immunogen.
    Cruz LJ, Iglesias E, Aguilar JC, González LJ, Reyes O, Albericio F, Andreu D.
    Bioconjug Chem; 2004 Jan 17; 15(1):112-20. PubMed ID: 14733590
    [Abstract] [Full Text] [Related]

  • 12. Immunogenicity and in vitro protective efficacy of a polyepitope Plasmodium falciparum candidate vaccine constructed by epitope shuffling.
    Cai Q, Peng G, Bu L, Lin Y, Zhang L, Lustigmen S, Wang H.
    Vaccine; 2007 Jul 09; 25(28):5155-65. PubMed ID: 17548134
    [Abstract] [Full Text] [Related]

  • 13. Method for the synthesis of highly pure vaccines using the lipid core peptide system.
    Moyle PM, Olive C, Good MF, Toth I.
    J Pept Sci; 2006 Dec 09; 12(12):800-7. PubMed ID: 17131293
    [Abstract] [Full Text] [Related]

  • 14. Synthesis, solution conformation, and antibody recognition of oligotuftsin-based conjugates containing a beta-amyloid(4-10) plaque-specific epitope.
    Manea M, Hudecz F, Przybylski M, Mezõ G.
    Bioconjug Chem; 2005 Dec 09; 16(4):921-8. PubMed ID: 16029033
    [Abstract] [Full Text] [Related]

  • 15. Fully synthetic immunogens. Part III. Synthesis of hinge-peptide/gastrin conjugates and their immunological properties.
    Wünsch E, Moroder L, Hübener G, Musiol HJ, Von Grünigen R, Göhring W, Scharf R, Schneider CH.
    Int J Pept Protein Res; 1991 Feb 09; 37(2):90-102. PubMed ID: 1708369
    [Abstract] [Full Text] [Related]

  • 16. Improved efficacy of DNA vaccination against prostate carcinoma by boosting with recombinant protein vaccine and by introduction of a novel adjuvant epitope.
    Lu Y, Ouyang K, Fang J, Zhang H, Wu G, Ma Y, Zhang Y, Hu X, Jin L, Cao R, Fan H, Li T, Liu J.
    Vaccine; 2009 Aug 27; 27(39):5411-8. PubMed ID: 19616501
    [Abstract] [Full Text] [Related]

  • 17. Design, structural, and immuno-analytical properties of antigenic bioconjugates comprising a beta-amyloid-plaque specific epitope.
    Manea M, Przybylski M, Hudecz F, Mezö G.
    Biopolymers; 2008 Aug 27; 90(2):94-104. PubMed ID: 18183582
    [Abstract] [Full Text] [Related]

  • 18. Humoral immune responses to a protective peptide-conjugate against measles after different prime-boost regimens.
    Pütz MM, Ammerlaan W, Schneider F, Jung G, Muller CP.
    Vaccine; 2004 Oct 22; 22(31-32):4173-82. PubMed ID: 15474707
    [Abstract] [Full Text] [Related]

  • 19. Self-adjuvanting vaccine against group A streptococcus: application of fibrillized peptide and immunostimulatory lipid as adjuvant.
    Azmi F, Ahmad Fuaad AA, Giddam AK, Batzloff MR, Good MF, Skwarczynski M, Toth I.
    Bioorg Med Chem; 2014 Nov 15; 22(22):6401-8. PubMed ID: 25438764
    [Abstract] [Full Text] [Related]

  • 20. Peptide based vaccine design: synthesis and immunological characterization of branched polypeptide conjugates comprising the 276-284 immunodominant epitope of HSV-1 glycoprotein D.
    Mezo G, Dalmadi B, Mucsi I, Bosze S, Rajnavölgyl E, Hudecz F.
    J Pept Sci; 2002 Mar 15; 8(3):107-17. PubMed ID: 11931583
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.